CAS No:71963-77-4
Specification:USP/CP
Assay is above 99%
Usage: an antimalarial agent used to treat acute uncomplicated malaria, and usually administered in combination with lumefantrine for improved efficacy.

According to pharmacological study, Artemether has a direct kill effect on plasmodium at erythrocytic stage, but invalid at organizational stage. Clinical research shows that Artemether has none of toxic and side effects in clinical treatment of tertian malaria, even the time of malignant protozoon turn to negative is faster than aralen, especially superior for the treatment of malignant malaria and cerebral malaria in anti-aralen-protozoon-strains area.